Rick W. Van Leeuwen

Maastricht, LI 6229ER, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Phosphatidylinositol 4-Kinase IIIβ: A Therapeutic Target for Contractile Dysfunction in Hypertrophic Cardiomyocytes.

Phosphatidylinositol 4-Kinase IIIβ: A Therapeutic Target for Contractile Dysfunction in Hypertrophic Cardiomyocytes.

Journal: International journal of molecular sciences

Published: September 26, 2025

Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy.

Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy.

Journal: Circulation. Heart failure

Published: September 24, 2025

CCR2+ monocyte-derived macrophages drive cardiac hypertrophy in early HFpEF.

CCR2+ monocyte-derived macrophages drive cardiac hypertrophy in early HFpEF.

Journal: American journal of physiology. Heart and circulatory physiology

Published: May 27, 2025

Lipid-induced S-palmitoylation of Insulin-Responsive Aminopeptidase (IRAP) drives the onset of insulin resistance in the heart.

Lipid-induced S-palmitoylation of Insulin-Responsive Aminopeptidase (IRAP) drives the onset of insulin resistance in the heart.

Journal: Cellular and molecular life sciences : CMLS

Published: May 07, 2025

Cytotoxic T Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy.

Cytotoxic T Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy.

Journal: Circulation research

Published: October 21, 2024

Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease.

Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease.

Journal: JACC. Heart failure

Published: June 07, 2024

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry.

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry.

Journal: ESC heart failure

Published: October 04, 2021

Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure.

Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure.

Journal: Scientific reports

Published: October 05, 2018

SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis.

SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: February 08, 2018

AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism.

AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism.

Journal: Molecular therapy. Nucleic acids

Published: December 20, 2017

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: July 31, 2017

Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation.

Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: May 14, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026